Literature DB >> 21987775

The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase.

Peter Halfmann1, Gabriele Neumann, Yoshihiro Kawaoka.   

Abstract

Type I interferon (IFN) signaling is mediated through several signaling pathways, including the Janus kinase and signal transducer and activator (JAK-STAT) and p38 mitogen-activated protein (MAP) kinase pathways. The VP24 protein of Ebolavirus is an IFN antagonist, blocking type I IFN signaling through the JAK-STAT pathway. Here, we show that, in 293 cells, VP24 also interferes with the p38 MAP kinase pathway by blocking IFN-β-stimulated phosphorylation of p38-α. Similar inhibition was not observed in HeLa cells, suggesting cell type-specific differences in signal transduction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987775      PMCID: PMC3189987          DOI: 10.1093/infdis/jir325

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Viruses and interferons.

Authors:  G C Sen
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

4.  The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

Authors:  Zongdi Feng; Melissa Cerveny; Zhipeng Yan; Bin He
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

5.  Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Authors:  St Patrick Reid; Charalampos Valmas; Osvaldo Martinez; Freddy Mauricio Sanchez; Christopher F Basler
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

6.  Activation of the p38 mitogen-activated protein kinase by type I interferons.

Authors:  S Uddin; B Majchrzak; J Woodson; P Arunkumar; Y Alsayed; R Pine; P R Young; E N Fish; L C Platanias
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

7.  Involvement of p38 signaling pathway in interferon-alpha-mediated antiviral activity toward hepatitis C virus.

Authors:  Hisashi Ishida; Kazuyoshi Ohkawa; Atsushi Hosui; Naoki Hiramatsu; Tatsuya Kanto; Keiji Ueda; Tetsuo Takehara; Norio Hayashi
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

8.  Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.

Authors:  Shinji Watanabe; Tokiko Watanabe; Takeshi Noda; Ayato Takada; Heinz Feldmann; Luke D Jasenosky; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 9.  Viral tricks to grid-lock the type I interferon system.

Authors:  Gijs A Versteeg; Adolfo García-Sastre
Journal:  Curr Opin Microbiol       Date:  2010-06-10       Impact factor: 7.934

10.  Molecular determinants of Ebola virus virulence in mice.

Authors:  Hideki Ebihara; Ayato Takada; Darwyn Kobasa; Steven Jones; Gabriele Neumann; Steven Theriault; Mike Bray; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

View more
  18 in total

Review 1.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

2.  Predictive and comparative analysis of Ebolavirus proteins.

Authors:  Qian Cong; Jimin Pei; Nick V Grishin
Journal:  Cell Cycle       Date:  2015-07-09       Impact factor: 4.534

3.  Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Authors:  Philipp A Ilinykh; Ndongala M Lubaki; Steven G Widen; Lynnsey A Renn; Terence C Theisen; Ronald L Rabin; Thomas G Wood; Alexander Bukreyev
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  The ebolavirus VP24 interferon antagonist: know your enemy.

Authors:  Adrianna P P Zhang; Dafna M Abelson; Zachary A Bornholdt; Tong Liu; Virgil L Woods; Erica Ollmann Saphire
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

5.  Crystal structure of Marburg virus VP24.

Authors:  Adrianna P P Zhang; Zachary A Bornholdt; Dafna M Abelson; Erica Ollmann Saphire
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

6.  Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies.

Authors:  Philipp A Ilinykh; Jessica Graber; Natalia A Kuzmina; Kai Huang; Thomas G Ksiazek; James E Crowe; Alexander Bukreyev
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

7.  Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription.

Authors:  Andrey Ivanov; Palaniappan Ramanathan; Christian Parry; Philipp A Ilinykh; Xionghao Lin; Michael Petukhov; Yuri Obukhov; Tatiana Ammosova; Gaya K Amarasinghe; Alexander Bukreyev; Sergei Nekhai
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

8.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

9.  The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.

Authors:  Ndongala M Lubaki; Philipp Ilinykh; Colette Pietzsch; Bersabeh Tigabu; Alexander N Freiberg; Richard A Koup; Alexander Bukreyev
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Authors:  Ari Watt; Felicien Moukambi; Logan Banadyga; Allison Groseth; Julie Callison; Astrid Herwig; Hideki Ebihara; Heinz Feldmann; Thomas Hoenen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.